XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (75,669) $ (5,612)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization expense 3,726 3,673
Amortization of debt issuance costs 1,047 286
Equity-based compensation expense 8,938 56
Goodwill impairment 35,252 0
Provision for doubtful accounts 44 0
Deferred income tax expense (benefit) (1,594) (1,996)
Net decrease in fair value of derivatives (1,462) 0
Changes in assets and liabilities:    
Decrease (increase) in accounts receivable 758 (1,580)
(Increase) decrease in contract assets (226) 1,557
Decrease (increase) in prepaid expenses and other assets 535 (4,299)
Increase in accounts payable 874 2,251
(Decrease) increase in accrued liabilities (2,509) 5,227
(Decrease) increase in contract liabilities (2,048) 494
Increase in other liabilities 338 275
Net cash (used in) provided by operating activities (31,996) 332
Cash flows from investing activities:    
Acquisition of businesses, net of cash acquired (4,376) (224)
Purchases of property and equipment (508) (282)
Net cash used in investing activities (4,884) (506)
Cash flows from financing activities:    
Repurchase of shares as a result of forward share purchase agreements (100,896) 0
Repayment of short-term borrowings (2,312) 0
Payments for taxes related to net share settlement of equity awards (4) 0
Repayment of term loan 0 (550)
Net cash used in financing activities (103,212) (550)
Net decrease in cash and cash equivalents and restricted cash (140,092) (724)
Cash and cash equivalents and restricted cash at the beginning of period 169,921 9,704
Cash and cash equivalents and restricted cash at the end of the period 29,829 8,980
Supplemental schedule of non-cash investing and financing activities:    
Issuance of common stock as consideration for the acquisition of ProModel Corporation 7,501 0
Reconciliation of cash and cash equivalents and restricted cash:    
Cash and cash equivalents 29,829  
Restricted cash 0  
Cash and cash equivalents and restricted cash at end of the period $ 29,829 $ 8,980